Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;109:e158-e160
doi: 10.1161/01.CIR.0000124449.48800.C3
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mosca, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mosca, L.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Heart Disease in Women
*Heart Diseases
Related Collections
Right arrow Health policy and outcome research
Right arrow Lipids
Right arrow Obesity
Right arrow Behavioral/psychosocial - treatment
Right arrow Primary prevention
Right arrow Secondary prevention
Right arrow Behavioral/psychosocial - stroke
Right arrow Cerebrovascular disease/stroke
Right arrow Peripheral vascular disease
Right arrow Type 2 diabetes
Right arrow Glucose intolerance
Right arrow Exercise/exercise testing/rehabilitation
Right arrow Cardiovascular Nursing
Right arrow Behavioral Changes and Stroke
Right arrow Carotid Stenosis
Right arrow Embolic stroke
Right arrow Primary and Secondary Stroke Prevention
Right arrow Risk Factors for Stroke
Right arrow Anticoagulants
Right arrow Antiplatelets
Right arrow Other Stroke Treatment - Medical
Right arrow Epidemiology

(Circulation. 2004;109:e158-e160.)
© 2004 American Heart Association, Inc.


Cardiology Patient Page

Heart Disease Prevention in Women

Lori Mosca, MD, PhD

From Columbia University College of Physicians and Surgeons, New York, NY.

Correspondence to Lori Mosca, MD, PhD, Director, Preventive Cardiology, New York Presbyterian Hospital, 622 W 168th St, New York, NY 10032-3720. E-mail ljm10@columbia.edu


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

A recent national study conducted by the American Heart Association showed that fewer than 50% of American women know that heart disease is their leading killer. The study included more than 1000 women from many different racial and ethnic backgrounds. More women in this study knew that heart disease was women’s leading killer than in similar studies conducted in 1997 and 2000, but there’s still a lot of room for improvement.

Cardiovascular disease—the No. 1 cause of death in the United States—claims the lives of almost 500 000 women each year. That’s nearly one death every minute. Being aware of the risk of heart disease is important because it’s the first step in taking action to lower risk.

Because heart disease can often be prevented, the survey findings are an urgent call to action. The American Heart Association and 11 other leading national health organizations came together to develop comprehensive guidelines for heart disease prevention in women. They include a rating scale to express the strength of recommendations and the quality of research to support specific preventive therapies.

Each recommendation was categorized to help doctors and women decide which preventive therapies should or should not be used. A Class I category indicates that the type of therapy should be provided routinely. Class IIa indicates that most scientific evidence favors providing the type of therapy, whereas Class IIb indicates the usefulness of therapy is less well-established. Class III indicates that the type of therapy isn’t useful and may be harmful.

Being . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Circ Cardiovasc Qual OutcomesHome page
S. J. Lewis, K. M. Fox, M. F. Bullano, S. Grandy, and for the SHIELD Study Group
Knowledge of Heart Disease Risk Among SHIELD Respondents With Dyslipidemia
Circ Cardiovasc Qual Outcomes, May 1, 2009; 2(3): 207 - 212.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. L. Anderson, C. D. Adams, E. M. Antman, C. R. Bridges, R. M. Califf, D. E. Casey Jr, W. E. Chavey II, F. M. Fesmire, J. S. Hochman, T. N. Levin, et al.
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine
J. Am. Coll. Cardiol., August 14, 2007; 50(7): e1 - e157.
[Full Text] [PDF]


Home page
HeartHome page
J H Mieres
Review of the American Heart Association's guidelines for cardiovascular disease prevention in women
Heart, May 1, 2006; 92(suppl_3): iii10 - iii13.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. T. Willerson
March 16, 2004
Circulation, March 16, 2004; 109(10): 1195 - 1195.
[Full Text] [PDF]